icon-folder.gif   Conference Reports for NATAP  
 
  AASLD/EASL Special Conference
on Hepatitis C
New York City, New York
September 12 - 13
Back grey_arrow_rt.gif
 
 
 
Outcome analysis of ledipasvir/sofosbuvir (LDV/SOF) for the treatment of chronic hepatitis C infected genotype 1 patients in the UK.
 
 
  Reported by Jules Levin
AASLD/EASL Special Conference NY Sept 2014
 
Ines Guerra1, Sandrine Cure1, Lucile Marie1, Geoffrey Dusheiko2 | 1OptumInsight, Uxbridge, UK; 2UCL Institute for Liver and Digestive health, Royal free hospital

AASLDEASL1.gif

AASLDEASL2.gif

AASLDEASL3.gif

AASLDEASL4.gif

AASLDEASL5.gif